382 related articles for article (PubMed ID: 37175871)
21. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
Li L; Ni R; Zheng D; Chen L
Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
[TBL] [Abstract][Full Text] [Related]
22. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
Das PK; Islam F; Lam AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
Zhang D; Tang DG; Rycaj K
Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
25. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
26. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.
De Robertis M; Poeta ML; Signori E; Fazio VM
Semin Cancer Biol; 2018 Dec; 53():232-247. PubMed ID: 30130662
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells.
Shen C; Yang C; Xia B; You M
Cancer Lett; 2021 Mar; 500():244-252. PubMed ID: 33242560
[TBL] [Abstract][Full Text] [Related]
28. NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis.
Jewett A; Kos J; Fong Y; Ko MW; Safaei T; Perišić Nanut M; Kaur K
Semin Cancer Biol; 2018 Dec; 53():178-188. PubMed ID: 30081230
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival.
D'Antonio L; Fieni C; Ciummo SL; Vespa S; Lotti L; Sorrentino C; Di Carlo E
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927528
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
[TBL] [Abstract][Full Text] [Related]
31. A promising antitumor method: Targeting CSC with immune cells modified with CAR.
Huang B; Miao L; Liu J; Zhang J; Li Y
Front Immunol; 2022; 13():937327. PubMed ID: 36032145
[TBL] [Abstract][Full Text] [Related]
32. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
[TBL] [Abstract][Full Text] [Related]
33. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
34. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
Fang X; Yan Q; Liu S; Guan XY
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
36. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of Colon Cancer Stem Cells.
Hirata A; Hatano Y; Niwa M; Hara A; Tomita H
Adv Exp Med Biol; 2019; 1139():115-126. PubMed ID: 31134498
[TBL] [Abstract][Full Text] [Related]
38. The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
Emmink BL; Verheem A; Van Houdt WJ; Steller EJ; Govaert KM; Pham TV; Piersma SR; Borel Rinkes IH; Jimenez CR; Kranenburg O
J Proteomics; 2013 Oct; 91():84-96. PubMed ID: 23835434
[TBL] [Abstract][Full Text] [Related]
39. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.
Shrestha S; Banstola A; Jeong JH; Seo JH; Yook S
J Control Release; 2022 Aug; 348():518-536. PubMed ID: 35709876
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
